Literature DB >> 30225231

A clinicopathological study on IgG4-related ophthalmic disease.

Yuka Suimon1, Satoru Kase1, Kan Ishijima1, Hiromi Kanno-Okada2, Susumu Ishida1.   

Abstract

AIM: To investigate clinicopathological features of immunoglobulin G4-related ophthalmic disease (IgG4-ROD), and analyze the recurrence rates following systemic corticosteroid administration.
METHODS: We retrospectively searched clinical features, laboratory and histological findings based on the medical records of 21 patients with IgG4-ROD. All the patients examined in this study underwent surgical resection in the ocular adnexal lesions and underwent histological evaluation. This study further investigated clinical and histopathological features of 15 patients who received systemic corticosteroid after the resection.
RESULTS: The mean age of the patients consisting of 7 males (33%) and 14 females (67%) was 61y. Fourteen patients were diagnosed as definitive, and 2 and 5 patients were probable and possible IgG4-ROD, respectively. Eyelid swelling was an initial symptom in 11 patients (52%) who did not show systemic involvements at a diagnosis. Fifteen patients received systemic corticosteroid administration, and all showed remission of inflammation. Among them, 10 patients did not recur, whereas 5 patients (33%) recurred during tapering. There were no significant difference between patients with or without recurrence in clinicopathological features.
CONCLUSION: In this study, female patients are more predominant in IgG4-ROD. While inflammation recurs in one-third of patients, this study do not identify factors associated with recurrence after systemic corticosteroid administration.

Entities:  

Keywords:  IgG4-related ophthalmic disease; corticosteroid; histopathology; recurrence

Year:  2018        PMID: 30225231      PMCID: PMC6133882          DOI: 10.18240/ijo.2018.09.18

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  21 in total

1.  Ocular adnexal IgG4-related lymphoplasmacytic infiltrative disorder.

Authors:  Toshinobu Kubota; Suzuko Moritani; Masao Katayama; Hiroko Terasaki
Journal:  Arch Ophthalmol       Date:  2010-05

2.  The usefulness of infraorbital nerve enlargement on MRI imaging in clinical diagnosis of IgG4-related orbital disease.

Authors:  Koh-Ichi Ohshima; Yuka Sogabe; Yasuharu Sato
Journal:  Jpn J Ophthalmol       Date:  2012-05-30       Impact factor: 2.447

3.  IgG4-related lacrimal sac diverticulitis.

Authors:  Satoru Kase; Yasuo Suzuki; Toshiya Shinohara; Manabu Kase
Journal:  Orbit       Date:  2014-02-25

4.  Serologic factors in early relapse of IgG4-related orbital inflammation after steroid treatment.

Authors:  Toshinobu Kubota; Masao Katayama; Suzuko Moritani; Tadashi Yoshino
Journal:  Am J Ophthalmol       Date:  2012-10-27       Impact factor: 5.258

5.  Orbital inflammation with IgG4-positive plasma cells: manifestation of IgG4 systemic disease.

Authors:  José Antonio Plaza; James A Garrity; Ahmet Dogan; Anuradha Ananthamurthy; Thomas E Witzig; Diva R Salomão
Journal:  Arch Ophthalmol       Date:  2011-04

6.  Inhibitory effect of estrogen receptor beta on P2X3 receptors during inflammation in rats.

Authors:  Qian Jiang; Wen-Xin Li; Jia-Run Sun; Tian-Tian Zhu; Juan Fan; Li-Hua Yu; Geoffrey Burnstock; Hua Yang; Bei Ma
Journal:  Purinergic Signal       Date:  2016-11-05       Impact factor: 3.765

7.  Spontaneous regression of IgG4-related dacryoadenitis.

Authors:  Satoru Kase; Teppei Yamamoto; Kan Ishijima; Mika Noda; Susumu Ishida
Journal:  Mod Rheumatol       Date:  2012-08-11       Impact factor: 3.023

Review 8.  IgG4-related orbital disease: a meta-analysis and review.

Authors:  Nicholas Andrew; Daniel Kearney; Dinesh Selva
Journal:  Acta Ophthalmol       Date:  2012-09-11       Impact factor: 3.761

9.  Risk factors for extraophthalmic involvement and treatment outcomes in patients with IgG4-related ophthalmic disease.

Authors:  Jinku Park; Min Joung Lee; Namju Kim; Ji Eun Kim; Sun-Won Park; Ho-Kyung Choung; Sang In Khwarg
Journal:  Br J Ophthalmol       Date:  2017-09-28       Impact factor: 4.638

Review 10.  IgG4-related sclerosing disease, an emerging entity: a review of a multi-system disease.

Authors:  Mukul Divatia; Sun A Kim; Jae Y Ro
Journal:  Yonsei Med J       Date:  2012-01       Impact factor: 2.759

View more
  3 in total

1.  Evaluation of Orbital Lymphoproliferative and Inflammatory Disorders by Gene Expression Analysis.

Authors:  Karim Al-Ghazzawi; Sven Holger Baum; Roman Pförtner; Svenja Philipp; Nikolaos Bechrakis; Gina Görtz; Anja Eckstein; Fabian D Mairinger; Michael Oeverhaus
Journal:  Int J Mol Sci       Date:  2022-08-03       Impact factor: 6.208

2.  Surgical management for IgG4-related ophthalmic disease by a transcranial biopsy combined with extraorbital decompression: illustrative case.

Authors:  Ryuichi Noda; Tomohiro Inoue; Sho Tsunoda; Atsuya Akabane
Journal:  J Neurosurg Case Lessons       Date:  2021-02-22

3.  The natural course of IgG4-related ophthalmic disease after debulking surgery: a single-centre retrospective study.

Authors:  Jun Ominato; Tokuhide Oyama; Hiroyuki Cho; Naoya Shiozaki; Hajime Umezu; Jun Takizawa; Takeo Fukuchi
Journal:  BMJ Open Ophthalmol       Date:  2019-08-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.